ArticleScientific reports2025
Trajectory of serum osmolality changes and 28-day mortality risk in patients with sepsis-associated delirium based on the MIMIC-IV database.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Serum osmolality (SOSM) levels have been reported to be associated with the prognosis of critically ill patients. The purpose of this study was to analyze the impact of the trajectory of changes in SOSM on the 28-day mortality risk in patients with sepsis-associated delirium (SAD). Latent class trajectory modeling (LCTM) was employed in this retrospective cohort study of patients with SAD from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. SOSM trajectories were derived using LCTM based on three measurements obtained at two-day intervals during the first six days following ICU admission. The relationship between the SOSM and 28-day mortality risk was explored using restricted cubic spline (RCS), Cox regression models, and Kaplan-Meier curves. Subgroup analyses were conducted to examine the association and stability of SOSM trajectories with SAD patients' outcome. Among the 3100 SAD patients included in the analysis, 488 (15.7%) died within 28 days. The median SOSM level was 294.8 (IQR 288.1-302.0) mmol/L. LCTM identified four distinct SOSM trajectories: normal-level-steady trend trajectory (Class 1), normal-level-increasing trend trajectory (Class 2), normal-level-decreasing and then increasing trend trajectory (Class 3), and normal-level-increasing and then decreasing trend trajectory (Class 4). Elevated baseline SOSM levels were independently associated with higher 28-day mortality (HR 1.02, 95% CI 1.01-1.03). RCS revealed a positive linear association between baseline SOSM levels and 28-day mortality risk (P overall < 0.001; P non-linearity = 0.87). Compared with Class 1, patients in Class 2 (HR 1.62, 95% CI 1.31-2.01), Class 3 (HR 1.71, 95% CI 1.19-2.47), and Class 4 (HR 1.99, 95% CI 1.39-2.84) exhibited significantly increased 28-day mortality risk. Subgroup analyses further demonstrated that the trajectory 2 was consistently associated with 28-day mortality in SAD patients aged over 60 years. SOSM was an independent risk factor for 28-day mortality in patients with SAD. Persistent elevation and fluctuation of SOSM trajectories after ICU admission were associated with increased 28-day mortality in patients with SAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.